The role of cGMP signalling in auditory processing in health and disease.
Philine MarchettaLukas RüttigerAdrian J HobbsWibke SingerMarlies KnipperPublished in: British journal of pharmacology (2021)
cGMP is generated by the cGMP-forming guanylyl cyclases (GCs), the intracellular nitric oxide (NO)-sensitive (soluble) guanylyl cyclase (sGC) and transmembrane GC (e.g. GC-A and GC-B). In summarizing the particular role of cGMP signalling for hearing, we show that GC generally do not interfere significantly with basic hearing function but rather sustain a healthy state for proper temporal coding, fast discrimination and adjustments during injury. sGC is critical for the integrity of the first synapse in the ascending auditory pathway, the inner hair cell synapse. GC-A promotes hair cell stability under stressful conditions such as acoustic trauma or ageing. GC-B plays a role in the development of efferent feed-back and gain control. Regarding the crucial role hearing has for language development, speech discrimination and cognitive brain functions, differential pharmaceutical targeting of GCs offers therapeutic promise for the restoration of hearing.
Keyphrases
- nitric oxide
- hearing loss
- gas chromatography
- protein kinase
- single cell
- nitric oxide synthase
- cell therapy
- healthcare
- hydrogen peroxide
- autism spectrum disorder
- machine learning
- mental health
- cancer therapy
- risk assessment
- white matter
- drug delivery
- reactive oxygen species
- mesenchymal stem cells
- high resolution
- coronary artery
- blood brain barrier
- brain injury
- bone marrow
- functional connectivity